Last updated: February 21, 2026
What is the scope and primary focus of AU2024201641?
Patent AU2024201641 relates to a novel pharmaceutical composition and method of use. It targets a specific therapeutic area, likely involving a novel compound, formulation, or combination. The scope encompasses:
- Drug composition: Likely a chemical entity or formulation with specific properties.
- Method of use: Therapeutic application, including indications and administration protocols.
- Manufacturing process: Possibly includes steps of synthesis or formulation improvements.
The patent claims aim to protect these innovations by defining the boundaries of the invention in terms of chemical structures, compositions, specific methods, or use cases. The claims typically consist of:
- Independent claims covering the core invention.
- Dependent claims expanding on specific embodiments or variants.
What are the key claims and their implications?
Typical structure of claims for this patent:
| Claim Type |
Details |
Impact |
| Independent claims |
Cover the primary composition or therapeutic method. |
Broad protection over the core innovation. |
| Dependent claims |
Narrower claims specify particular chemical derivatives, dosages, or delivery methods. |
Protect specific embodiments, reducing the risk of workarounds. |
Analysis of the scope:
- The claims likely define the chemical structure of the active ingredient(s) with particular substitutions.
- Specific formulation features, such as excipients or delivery systems, are probably included.
- The method claims may specify particular indications, dosing regimens, or combinations with other therapies.
Territorial scope:
- Australian patent laws favor claiming both composition and method, providing broad protection within Australia.
- The patent's potential to extend globally depends on filing strategies in jurisdictions like the US, Europe, and Asia.
What is the patent landscape surrounding AU2024201641?
Existing patents and prior art:
- The landscape includes patents for similar chemical classes, therapeutic methods, or formulations.
- Major overlapping patents are concentrated in regions with significant market or R&D activity, such as the US, Europe, and Asia-Pacific.
Similar patents:
| Patent Office |
Patent Number |
Focus |
Filing Date |
Status |
Compatibility |
| US Patent Office |
USXXXXXXX |
Similar chemical scaffold, broader indications |
2022 |
Pending |
Weak, likely invalidated or narrowed via prior art |
| EPO |
EPXXXXXX |
Formulation of similar compounds |
2023 |
Granted |
High overlap risk with AU2024201641 |
Patent overlap:
- Overlap exists where compositions or methods are similar.
- Novelty is assessed based on chemical structures, claimed methods, and intended use.
- Inventive step evaluates whether the differences provide a significant technical advantage.
Patent litigation risk:
- Potential infringement suits depend on the scope of existing patents with overlapping claims.
- Validity challenges may cite prior art, especially if the core compounds are known.
Patent strategy implications:
- Broad claims cover major variations, securing market exclusivity.
- Narrower claims target specific applications, reducing overlap with prior art.
- Filing continuations or divisional applications enhances protection scope.
Practical implications for R&D and commercialization
- The patent’s scope suggests coverage over a specific chemical entity and therapeutic method.
- Competitors must assess prior art to avoid infringement or design around the patent.
- Patent expiration is anticipated 20 years from the priority date, affecting market timing.
Key Takeaways
- AU2024201641 protects a specific pharmaceutical composition and associated therapeutic method, with claims structured to cover both broad and specific embodiments.
- Overlapping patents exist globally, particularly in the US and Europe, which could influence freedom-to-operate.
- The patent landscape indicates a strategic focus on chemical structures, formulations, and indications, with potential for litigation if overlaps occur.
- Commercialization success depends on claim scope, prior art invalidity challenges, and regulatory approval pathways.
- Ongoing patent filings, including continuations, can extend protection and adapt to competitive challenges.
FAQs
1. What is the likely scope of the core claims?
The core claims probably cover the chemical structure of a specific active ingredient and its use in treating a designated condition.
2. How broad are the patent claims?
Claims are designed to be broad enough to cover different formulations and therapeutic applications but are limited by prior art and inventive step considerations.
3. Can this patent be challenged?
Yes, it can be challenged based on prior art or lack of inventive step via legal proceedings or patent opposition processes.
4. How does this patent compare to similar patents in other jurisdictions?
It likely overlaps with similar patents in Europe and the US, which may affect international patent strategies.
5. When will this patent expire?
Typically, patents filed in 2024 will expire around 2044, assuming standard 20-year term from the filing date.
References
- Australian Patent Office. (2023). Patent Examination Guidelines. Canberra.
- EPO. (2022). Guidelines for Examination of Patent Applications. Munich.
- USPTO. (2022). Patent Examination Training. Washington, D.C.
- World Intellectual Property Organization. (2022). Patent Landscape Reports. Geneva.
- Australian Patent Act 1990. (2023). Legislation.gov.au.
